Live Breaking News & Updates on Scott plesha

Stay informed with the latest breaking news from Scott plesha on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Scott plesha and stay connected to the pulse of your community

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI

JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to...

United-states , Primrose-bio , Scott-plesha , Todd-davis , Michael-jeong , Bob-yedid , Kellie-walsh , Oclassen-dermatologics , Drug-administration , Biodelivery-sciences , Gilead-sciences , Solvay-pharmaceuticals

Ligand Pharma (LGND) Launches Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI

Ligand Pharma (LGND) Launches Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Primrose-bio , Scott-plesha , Todd-davis , Oclassen-dermatologics , Gastrointestinal-sales-at-salix-pharmaceuticals , Solvay-pharmaceuticals , Ligand-pharmaceuticals-nasdaq , Novan-inc , Drug-administration , Biodelivery-sciences , Ligand-pharmaceuticals

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™

Pharmaceutical executive Scott Plesha named CEO

Lead product ZELSUVMI expected to be commercially available in late 2024

...

United-states , Oclassen-dermatologics , Primrose-bio , Scott-plesha , Todd-davis , Ligand-pharmaceuticals , Novan-inc , Ligand-pharmaceuticals-nasdaq , Biodelivery-sciences , Baxter-international , Solvay-pharmaceuticals , Pfizer

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMItm

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMItm
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Primrose-bio , Todd-davis , Oclassen-dermatologics , Scott-plesha , Product-service , Baxter-international , Pfizer , Amgen , Ligand-pharmaceuticals , Gilead-sciences , Gastrointestinal-sales-at-salix-pharmaceuticals

Ligand Pharmaceuticals Announces Launch Of Pelthos; Scott Plesha To Assume Leadership Of Pelthos

Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned subsidiary of Ligand. Pelthos is committed to commercializing therapeutic products to help patients impacted by diseases with limited treatment options.

Scott-plesha , More-such-health-news , Ligand-pharmaceuticals , Biodelivery-sciences , Pelthos-therapeutics , Chief-executive , Chief-commercial-officer , Collegium-pharmaceutical ,

Ligand Pharmaceuticals Announces Launch Of Pelthos; Scott Plesha To Assume Leadership Of Pelthos

(RTTNews) - Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned sub...

Scott-plesha , More-such-health-news , Biodelivery-sciences , Ligand-pharmaceuticals , Pelthos-therapeutics , Chief-executive , Chief-commercial-officer , Collegium-pharmaceutical ,

BioDelivery Sciences International, inc (BDSI) Q3 2021 Earnings Call Transcript

BDSI earnings call for the period ending October 31, 2021.

Delaware , United-states , Chicago , Illinois , American , Tim-chiang , Terry-coelho , Scott-plesha , Jeff-bailey , Mary-theresa-coelho , John-golubieski , Jeffrey-allen-bailey

Biodelivery Sciences International Inc (BDSI) Q1 2021 Earnings Call Transcript

Greetings. Welcome to BioDelivery Sciences' First Quarter 2021 Earnings Call. [Operator Instructions]
I would now like to turn the conference over to Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. You may begin.
Terry Coelho --
Executive Vice President and Chief Financial Officer
Thank you and good morning, everyone. Welcome to our first quarter 2021 earnings conference call. Leading the call today is Jeff Bailey, Chief Executive Officer. We are joined by Scott Plesha, President and Chief Commercial Officer. Following our prepared remarks, we will conduct a question-and-answer session.
Earlier today, BioDelivery Sciences issued a press release announcing its financial results for the first quarter of 2021. A copy of the release can be found on the Investor Relations page of the Company's website. Before we begin, I would like to remind everyone that certain statements may be made during this call which may contain forward-looking statements. Such forward-looking statements are based upon current expectations and there can be no assurances that the results contemplated in these statements will be realized. Actual results may differ materially from such statements due to a number of factors and risks, some of which are identified in our press release and our annual, quarterly and other reports filed with the SEC. These forward-looking statements are based on information available to BDSI today, May 6, 2021, and the Company assumes no obligation to update statements as circumstances change. An audio recording and broadcast replay for today's conference call will also be available online in the Investors section of the Company's website.

Tennessee , United-states , Terry-coelho , Scott-plesha , Jeff-bailey , Piper-sandler , Lachlan-hanbury-brown-william-blair , Zach-sachar-piper-sandler , Brandon-folkes-cantor-fitzgerald , Gregg-gilbert , Tim-lugo , Scott-henry

Biodelivery Sciences International Inc (BDSI) Q4 2020 Earnings Call Transcript

Operator
Greetings, and welcome to the BioDelivery Sciences Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions]
It is now my pleasure to introduce your host, Ms. Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. Please go ahead.
Terry Coelho --
Executive Vice President and Chief Financial Officer
Thank you, and good morning, everyone. Welcome to our fourth quarter 2020 earnings conference call. Leading the call today is Jeff Bailey, Chief Executive Officer. We are joined by Scott Plesha, President and Chief Commercial Officer. Following our prepared remarks, we will conduct a question-and-answer session. Earlier today BioDelivery Sciences issued a press release announcing its financial results for the fourth quarter and full year 2020. A copy of the release can be found on the Investor Relations page of the company's website.

Texas , United-states , Terry-coelho , Brandon-folkes-cantor-fitzgerald , Tim-chiang-northland , Tim-chiang , Jeff-bailey , Tim-lugo-william-blair , Scott-plesha , Piper-sandler , Gregg-gilbert , Tim-lugo